ALK-IN-31
ALK-IN-31 (Compound Ld-10) is an orally active ALK inhibitor (IC50: 1135 nM) . ALK-IN-31 exhibits excellent antiproliferative activity against lung cancer H2228 cells with an IC50 value of 1.35 μM. ALK-IN-31 induces apoptosis and arrests cell proliferation in the G0/G1 phase by affecting mitochondrial function. ALK-IN-31 exerts its anti-tumor effect by downregulating the expression of p-AKT and p-mTOR in the PI3K-AKT-mTOR signaling pathway downstream of ALK. ALK-IN-31 can be used in the study of non-small cell lung cancer (NSCLC) [1].
Product Specifications
CAS Number
3043840-25-8
UNSPSC
12352005
Target
Akt; Anaplastic lymphoma kinase (ALK) ; Apoptosis; mTOR
Related Pathways
Apoptosis; PI3K/Akt/mTOR; Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Smiles
O=C(C1CCCCC1)NC2=CC=CC=C2NC3=C(CSCC4)C4=NC(NC(C=C5CCC6)=CC=C5C6=O)=N3
Molecular Formula
C30H33N5O2S
Molecular Weight
527.68
References & Citations
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
ASM3A, CT (SMPDL3A, ASML3A, Acid sphingomyelinase-like phosphodiesterase 3a) (MaxLight 650)
ASM3A, CT (SMPDL3A, ASML3A, Acid sphingomyelinase-like phosphodiesterase 3a) (MaxLight 650)
Phospho-PLCG 2 (Tyr759) Rabbit Polyclonal Antibody (Cy7)